AARTIDRUGS Intraday Analysis...

AARTIDRUGS Share Price

Open 637.00 Change Price %
High 648.50 1 Day -0.25 -0.04
Low 637.00 1 Week 14.40 2.28
Close 646.95 1 Month 31.45 5.11
Volume 8780 1 Year 91.25 16.42
52 Week High 686.45
52 Week Low 431.60
AARTIDRUGS Important Levels
Resistance 2 657.61
Resistance 1 653.22
Pivot 644.15
Support 1 640.68
Support 2 636.29
NSE INDIA Most Active Stocks
UNITECH 4.55 -4.21%
ADANIPOWER 31.10 6.69%
CROMPGREAV 68.35 -10.42%
SUNTV 492.60 12.80%
HCC 39.75 -1.97%
HCC 39.75 -1.97%
ASHOKLEY 77.20 3.35%
JPASSOCIAT 7.65 1.32%
HINDALCO 174.50 3.41%
SBIN 256.90 1.10%
More..
NSE INDIA Top Gainers Stocks
KSERASERA 0.20 33.33%
RAJRAYON 0.30 20.00%
LOTUSEYE 31.95 19.66%
RAJTV 68.90 19.31%
SOMICONVEY 59.75 18.43%
ARIHANT 60.80 17.83%
VISASTEEL 19.35 13.16%
SUNTV 492.60 12.80%
MVL 0.45 12.50%
MVL 0.45 12.50%
More..
NSE INDIA Top Losers Stocks
FCSSOFT 0.25 -16.67%
AUSTRAL 0.30 -14.29%
CROMPGREAV 68.35 -10.42%
SHYAMCENT 9.90 -9.59%
PRAKASH 43.45 -9.57%
NICCO 0.50 -9.09%
SPYL 1.85 -7.50%
DREDGECORP 381.70 -6.37%
TVTODAY 293.80 -6.25%
BALLARPUR 15.65 -6.01%
More..

Aarti Drugs Limited (NSE: AARTIDRUGS)

AARTIDRUGS Technical Analysis 5
As on 5th Dec 2016 AARTIDRUGS Share Price closed @ 646.95 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 519.06 & Strong Buy for SHORT-TERM with Stoploss of 617.64 we also expect STOCK to react on Following IMPORTANT LEVELS.
AARTIDRUGS Target for December
1st Target up-side 733
2nd Target up-side 793.91
3rd Target up-side 854.82
1st Target down-side 559.2
2nd Target down-side 498.29
3rd Target down-side 437.38
AARTIDRUGS Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 60.62 Sideways
MFI (14) MFI is 69.65 Sideways
CCI (20) CCI is Above 100 Over Bought
WILLIAM %R (14) William %R is Above -20 Over Bought
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Long Buy 548.24
10 Day Avg Volume Traded 14.45 % More then 10 Day Average Volume
AARTIDRUGS Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.aartidrugs.com
AARTIDRUGS Address
AARTIDRUGS
Mahendra Industrial Estate
Ground Floor
Mumbai, 400022
India
Phone: 91 22 2401 9025
Fax: 91 22 2407 3462
AARTIDRUGS Latest News
Aarti Drugs Ltd Fixes Record Date for 1:1 Bonus Issue   Equity Bulls   - 19th Mar 15
Aarti Drugs - Board Meeting on March 26, 2015   Moneycontrol.com   - 17th Mar 15
Newspapers Advertisement of Result of Postal Ballot   Hindu Business Line   - 16th Mar 15
Here are six things that you need to know about Aarti Drugs   Moneycontrol.com   - 16th Feb 15
Aarti Drugs hits new high on 1:1 bonus issue; strong Q3 results   Business Standard   - 02nd Feb 15
Aarti Drugs Board approves bonus issue   Indiainfoline   - 30th Jan 15
Aarti Drugs to consider second interim dividend   Moneycontrol.com   - 19th Jan 15
Buy Aarti Drugs; target of Rs 1031: Sunidhi Securities   Moneycontrol.com   - 12th Aug 14
Aarti Drugs eyes to buy a Baddi company for toll manufacturing   Business Standard   - 07th Jul 14
USFDA issues warning letter to Mumbai-based Aarti Drugs   Business Standard   - 25th Sep 13
Interactive Technical Analysis Chart Aarti Drugs Limited ( AARTIDRUGS NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Aarti Drugs Limited
AARTIDRUGS Business Profile
Aarti Drugs Limited was incorporated on 28th September, 1984 as a Private Limited Company and then it was converted into a Public Limited Company on 1st July, 1992.The Company has established a strong presence in the Anti-diarrhea, Anti-inflammatory therapeutic groups. With its manufacturing facilities at Tarapur and Sarigam, the Company manufactures Vitamins, Anti-arthritis, Anti-fungal, Antibiotics, ACE inhibitors, besides its range in , anti-diabetic, anti-cholinergic, sedatives and anti-depressant drugs.The manufacturing-units of ADL are GMP certified. The Company is also in the process of acquiring an ISO 9002 compliance for all its units and one of the units has already been approved. Aarti Drugs has reported a standalone sales turnover of Rs 218.64 crore and a net profit of Rs 11.84 crore for the quarter ended June 2013. The registered office is at Plot No. N - 198, M.I.D.C., Tarapur, Village - Pamtembhi, Taluka - Palghar, District Thane - 401 506 in Maharashtra and Corporate office is at Mahendra Industrial Estate, Ground Floor, Road No 29, Plot No 109-D, SION, Mumbai.